About Fortrea
Fortrea is a company based in Durham (United States) founded in 2015. The company has 15,500 employees as of December 31, 2024. Fortrea operates in a competitive market with competitors including Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
- Headquarter Durham, United States
- Employees 15500 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Fortrea Holdings Inc.
-
Annual Revenue
$2.7 B (USD)-5.14as on Dec 31, 2024
-
Net Profit
-$308.9 M (USD)-1125.79as on Dec 31, 2024
-
EBITDA
-$26.5 M (USD)-118.6as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
15500
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Fortrea
Fortrea is a publicly listed company on the NASDAQ with ticker symbol FTRE in USA, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Fortrea
Unlock access to complete
Software Development Team
66 people
Leadership Team
64 people
Data Analysis and Operations Team
63 people
Senior Team
62 people
Clinical Team
47 people
Operations Team
45 people
Finance and Accounting
18 people
Sales and Marketing
17 people
Unlock access to complete
Funding Insights of Fortrea
Detailed funding history for Fortrea
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Fortrea
Investment portfolio details for Fortrea
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Fortrea
Detailed financials for Fortrea
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Fortrea Comparisons
Peer comparison for Fortrea
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Fortrea
Fortrea operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eurofins Scientific, WuXi AppTec, Ipsen, CHEPLAPHARM and ANI Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Laboratory testing and contract research services are provided globally.
|
|
| Locked | Locked | Locked |
Provider of CRO and CDMO services
|
|
| Locked | Locked | Locked |
Biopharmaceutical company focused on developing and commercializing innovative treatments in oncology, rare disease, and neuroscience to improve patient health outcomes
|
|
| Locked | Locked | Locked |
Branded pharmaceutical products are developed, marketed, and distributed globally.
|
|
| Locked | Locked | Locked |
Branded and generic prescription drugs are developed, manufactured, and marketed.
|
|
| Locked | Locked | Locked |
CRO focused on clinical development for phases II & III clinical trials and regulatory affair services
|
Detailed competitors of Fortrea
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Fortrea
Complete news archive for Fortrea
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fortrea
Fortrea was founded in 2015.
Fortrea is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
As of Dec 31, 2024, the latest employee count at Fortrea is 15,500.
Annual revenue of Fortrea is $2.7B as on Dec 31, 2024.
Fortrea was established in 2015 and is headquartered in Durham, United States. Operations focus on the clinical research and healthcare sectors, where early and late phase clinical development services are delivered alongside market access solutions and health economics and outcomes research (HEOR) strategies. These offerings support pharmaceutical and biotech clients in navigating development pipelines and reimbursement processes across global markets.
Fortrea's top competitors include WuXi AppTec, ANI Pharmaceuticals and Aptar.
Yes, Fortrea is publicly traded on NASDAQ under the ticker symbol FTRE.
The ticker symbol of Fortrea is FTRE on NASDAQ.